Sector Update: Health Care Stocks Advance in Afternoon Trading

MT Newswires Live08-20

Health care stocks were higher Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each rising about 0.5%.

The iShares Biotechnology ETF (IBB) spiked 1.2%.

In corporate news, Alzamend Neuro (ALZN) shares rallied 320% after the drugmaker said it's teaming up with Massachusetts General Hospital for a phase 2 trial of its lithium therapeutic drug candidate AL001 for post-traumatic stress disorder.

Liquidia (LQDA) shares sank 31%. The company said it has received tentative US Food and Drug Administration approval for its drug Yutrepia to treat adults with pulmonary arterial hypertension and pulmonary hypertension related to lung disease. However, final approval can only be granted after the 2025 expiration of the exclusivity period for United Therapeutics' (UTHR) Tyvaso DPI. United shares jumped 8%.

Sonnet BioTherapeutics (SONN) shares popped 4% after the firm said it's collaborating with the Sarcoma Oncology Center to advance the development of SON-1210 in combination with chemotherapy for metastatic pancreatic cancer.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2460262050?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-20 02:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2460262050","market":"sh","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Advance in Afternoon Trading","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were higher Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each rising about 0.5%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) spiked 1.2%.</p><p>In corporate news, Alzamend Neuro (ALZN) shares rallied 320% after the drugmaker said it's teaming up with Massachusetts General Hospital for a phase 2 trial of its lithium therapeutic drug candidate AL001 for post-traumatic stress disorder.</p><p>Liquidia (LQDA) shares sank 31%. The company said it has received tentative US Food and Drug Administration approval for its drug Yutrepia to treat adults with pulmonary arterial hypertension and pulmonary hypertension related to lung disease. However, final approval can only be granted after the 2025 expiration of the exclusivity period for United <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>' (UTHR) Tyvaso DPI. United shares jumped 8%.</p><p>Sonnet BioTherapeutics (SONN) shares popped 4% after the firm said it's collaborating with the Sarcoma Oncology Center to advance the development of SON-1210 in combination with chemotherapy for metastatic pancreatic cancer.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Advance in Afternoon Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Advance in Afternoon Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-20 02:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Health care stocks were higher Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each rising about 0.5%.The iShares Biotechnology ETF (IBB) spiked ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XLV","symbol_name":"健康照护类股ETF-SPDR","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2460262050","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2460262050","pubTimestamp":1724091180,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were higher Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund  each rising about 0.5%.The iShares Biotechnology ETF  spiked 1.2%.In corporate news, Alzamend Neuro  shares rallied 320% after the drugmaker said it's teaming up with Massachusetts General Hospital for a phase 2 trial of its lithium therapeutic drug candidate AL001 for post-traumatic stress disorder.Liquidia  shares sank 31%. The company said it has received tentative US Food and Drug Administration approval for its drug Yutrepia to treat adults with pulmonary arterial hypertension and pulmonary hypertension related to lung disease. However, final approval can only be granted after the 2025 expiration of the exclusivity period for United Therapeutics'  Tyvaso DPI. United shares jumped 8%.Sonnet BioTherapeutics  shares popped 4% after the firm said it's collaborating with the Sarcoma Oncology Center to advance the development of SON-1210 in combination with chemo","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XLV":"健康照护类股ETF-SPDR","BK4539":"次新股","BK4588":"碎股","BK4581":"高盛持仓","BK4007":"制药","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","SONN":"Sonnet BioTherapeutics Holdings, Inc.","BK4532":"文艺复兴科技持仓","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","IBB":"生物科技指数ETF-iShares Nasdaq","UTHR":"美国联合医疗","BK4585":"ETF&股票定投概念","ALZN":"Alzamend Neuro, Inc","LQDA":"Liquidia Technologies Inc","BK4139":"生物科技"},"translate_title":"行业更新：医疗保健股在下午交易中上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALZN":1,"IBB":1,"XLV":1,"LQDA":0.9,"SONN":0.9,"UTHR":0.9},"content_text":"Health care stocks were higher Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each rising about 0.5%.The iShares Biotechnology ETF (IBB) spiked 1.2%.In corporate news, Alzamend Neuro (ALZN) shares rallied 320% after the drugmaker said it's teaming up with Massachusetts General Hospital for a phase 2 trial of its lithium therapeutic drug candidate AL001 for post-traumatic stress disorder.Liquidia (LQDA) shares sank 31%. The company said it has received tentative US Food and Drug Administration approval for its drug Yutrepia to treat adults with pulmonary arterial hypertension and pulmonary hypertension related to lung disease. However, final approval can only be granted after the 2025 expiration of the exclusivity period for United Therapeutics' (UTHR) Tyvaso DPI. United shares jumped 8%.Sonnet BioTherapeutics (SONN) shares popped 4% after the firm said it's collaborating with the Sarcoma Oncology Center to advance the development of SON-1210 in combination with chemotherapy for metastatic pancreatic cancer.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"Product Release","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2460262050"}